News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
740 Results
Type
Article (77)
Company Profile (1)
Press Release (662)
Section
Business (214)
Career Advice (1)
Deals (28)
Drug Development (188)
FDA (21)
Job Trends (11)
News (443)
Policy (50)
Tag
Academia (4)
Alliances (47)
Approvals (13)
Best Places to Work (7)
Biotechnology (1)
Cancer (2)
Career advice (2)
CDC (1)
Cell therapy (2)
Clinical research (157)
Collaboration (1)
Complete response letters (1)
COVID-19 (4)
C-suite (4)
Cystic fibrosis (1)
Data (3)
Earnings (68)
Editorial (2)
Events (100)
Executive appointments (3)
FDA (22)
Funding (1)
Gene editing (1)
Gene therapy (1)
GLP-1 (1)
Government (10)
Healthcare (5)
Infectious disease (4)
IPO (14)
Job creations (3)
Job search strategy (1)
Layoffs (3)
Leadership (1)
Legal (4)
Manufacturing (1)
Medical device (2)
Medtech (2)
Mergers & acquisitions (14)
Neuropsychiatric disorders (1)
Neuroscience (2)
NextGen: Class of 2026 (9)
Non-profit (3)
People (99)
Phase 1 (34)
Phase 2 (73)
Phase 3 (69)
Pipeline (5)
Policy (7)
Postmarket research (5)
Preclinical (17)
Radiopharmaceuticals (1)
Rare diseases (1)
Real estate (3)
Regulatory (46)
Research institute (1)
Series B (1)
Special edition (1)
Startups (7)
Tariffs (1)
Vaccines (4)
Date
Last 365 days (36)
2026 (1)
2025 (39)
2024 (33)
2023 (33)
2022 (41)
2021 (36)
2020 (59)
2019 (33)
2018 (18)
2017 (63)
2016 (30)
2015 (48)
2014 (30)
2013 (41)
2012 (40)
2011 (41)
2010 (33)
Location
Africa (1)
Asia (30)
Australia (8)
California (3)
Canada (1)
China (1)
Europe (102)
India (1)
Massachusetts (5)
Nevada (1)
New York (27)
Northern California (1)
Pennsylvania (2)
South America (1)
Southern California (2)
United States (37)
740 Results for "ovid therapeutics.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer
December 2, 2025
·
4 min read
Press Releases
Ovid Therapeutics Reports Phase 1 Results for the First-Ever Direct Activator of Potassium-Chloride Cotransporter 2 (KCC2), OV350 Intravenous (IV)
December 19, 2025
·
8 min read
Press Releases
Ovid Therapeutics Announces Planned Leadership Succession and Reports Business Updates and Third Quarter 2025 Financial Results
November 13, 2025
·
15 min read
Press Releases
Ovid Therapeutics Announces Pricing of Private Placement Totaling up to $175 Million in Gross Proceeds
October 6, 2025
·
7 min read
Press Releases
Ovid Therapeutics to Participate in the BTIG Virtual Biotech Conference
July 23, 2025
·
1 min read
Press Releases
Ovid Therapeutics Reports Business Updates and Second Quarter 2025 Financial Results
August 14, 2025
·
13 min read
Press Releases
Ovid announces positive topline results for the next-generation GABA-aminotransferase inhibitor, OV329, that demonstrate strong inhibitory activity and a potential best-in-category safety profile
October 6, 2025
·
14 min read
Press Releases
Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties
June 25, 2025
·
5 min read
Press Releases
Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025
June 5, 2025
·
4 min read
Press Releases
Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results
May 13, 2025
·
11 min read
1 of 74
Next
